is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological ... and glutamate modulators. Both therapeutic strategies could ...

Published in Neuroelectronics, this breakthrough has the potential to improve neural modulation and brain-machine interface devices, ensuring safer and more effective treatments for neurological ...

A team led by Professor Krzysztof Kamiński from Poland’s Jagiellonian University has developed a new molecule which could ...

Groundbreaking research has transformed our understanding of acupuncture's role in treating sciatica, a debilitating ...

Challenges in Building a Drone Marketplace: Key Insights and Lessons ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site http://mc.manuscriptcentral ...

and there are varying types of leg pain according to where in the body the pain stems. Types include: Neurological leg pain ...

DUNDEE, Scotland & SAN FRANCISCO--(BUSINESS WIRE)--Ubiquigent Limited (“Ubiquigent”), a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new ...

such as sleep disorders and neurological pain. We’re excited to enter the enterprise market so that we can help more people get the care they need. I’ve been there, so I know how much they ...

Autoimmune neurological diseases are conditions where the immune system attacks nerve cells. Damage to neuronal cells can lead to a variety of neurologic and psychiatric symptoms. Autoimmune ...

today unveiled enhancements to its Neuro AI Platform that allow enterprises to discover, prototype and develop artificial intelligence use cases rapidly. The enhancements allow businesses to ...